{"id":235655,"date":"2026-04-21T18:15:58","date_gmt":"2026-04-21T23:15:58","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/secondary-causes-of-diabetes-a-crossroad-of-endocrinology-and-oncology"},"modified":"2026-04-21T18:15:58","modified_gmt":"2026-04-21T23:15:58","slug":"secondary-causes-of-diabetes-a-crossroad-of-endocrinology-and-oncology","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/secondary-causes-of-diabetes-a-crossroad-of-endocrinology-and-oncology","title":{"rendered":"Secondary causes of diabetes: a crossroad of endocrinology and oncology"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/secondary-causes-of-diabetes-a-crossroad-of-endocrinology-and-oncology2.jpg\"><\/a><\/p>\n<p>Cancer and diabetes share a bidirectional relationship, with cancer increasingly recognised as an associated factor of diabetes, both from the disease itself and its treatments. In this Review, we aim to: summarise the distinct mechanisms of dysglycaemia arising from cancer and neuroendocrine tumour treatments, including targeted therapies such as PI3K\u2013AKT\u2013mTOR inhibitors, antibody\u2013drug conjugates, immune checkpoint inhibitors, corticosteroids, and somatostatin receptor ligands; examine the often overlooked aspect of the secondary cause of diabetes as an early manifestation of cancer; and highlight research gaps and encourage a collaborative care approach to manage the rising rate of dysglycaemia as a result of cancer and its evolving treatments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer and diabetes share a bidirectional relationship, with cancer increasingly recognised as an associated factor of diabetes, both from the disease itself and its treatments. In this Review, we aim to: summarise the distinct mechanisms of dysglycaemia arising from cancer and neuroendocrine tumour treatments, including targeted therapies such as PI3K\u2013AKT\u2013mTOR inhibitors, antibody\u2013drug conjugates, immune checkpoint [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-235655","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=235655"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235655\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=235655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=235655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=235655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}